A recent study showed that VAV1 acts as a tumor suppressor in leukemia by promoting the degradation of ICN1 (intracellular domain of Notch1), while VAV1 mutation facilitates the malignant transformation of T cells [46, 47]. This evidence concerns the gene NOTCH1 and leukemia.